Evaluation of Patients' Recovery from Hepatitis C Following Antiviral Treatment with Daclatasvir and Sofosbuvir in AL-Baha Region
The liver is the largest organ in the body, located below the diaphragm and protected by the lower ribs of the rib cage (Johns Hopkins Medicine, 2022). Many hepatitis viruses infect the liver, among them Hepatitis C, which currently has no effective vaccination (Lazarus et al., 2020; Park & Hahn...
Saved in:
| Main Authors: | Fahad Alghamdi, Rashed Mohammed |
|---|---|
| Format: | Article |
| Language: | deu |
| Published: |
Scientific Publishing Unit, Faculty of Education, Tanta University , Egypt
2024-06-01
|
| Series: | International Journal of Advanced Humanities Research |
| Subjects: | |
| Online Access: | https://ijahr.journals.ekb.eg/article_317444_2e064de0dfd572d35fdd9b707e5438c1.pdf |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
DEVELOPMENT AND VALIDATION OF A NEW RP-HPLC METHOD FOR SIMULTANEOUS DETERMINATION AND QUANTIFICATION OF SOFOSBUVIR AND DACLATASVIR
by: Syed Hassan Murtaza, et al.
Published: (2024-03-01) -
Impact of Sofosbuvir/Daclatasvir treatment on glycemic control and lipid profile in diabetic patients with chronic hepatitis C
by: Tamer Fouad, et al.
Published: (2025-07-01) -
Impact of Sofosbuvir Plus Daclatasvir Therapy on the Frequency of CD200R<sup>+</sup> Dendritic Cells in Chronic Hepatitis C Virus Infection
by: Helal F. Hetta, et al.
Published: (2024-12-01) -
Efficacy and safety of sofosbuvir plus daclatasvir in hemodialysis patients with genotype 1b or 2a hepatitis C virus infection: a single-arm, prospective real-world study
by: Kaili Wang, et al.
Published: (2025-07-01) -
Diagnostic approach to elucidate the efficacy and side effects of direct-acting antivirals in HCV infected patients
by: Sonia Younas, et al.
Published: (2021-10-01)